There is no simple answer for everyone
These adverse effects significantly contributed to the discontinuation rates, prompting concerns regarding medication adherence in diabetes care
This review examines the cost-effectiveness of commonly discussed treatment options: glucagon-like peptide-1 receptor agonists (GLP-1 RAs), endoscopic sleeve gastroplasty (ESG), and metabolic/bariatric surgery (MBS)
Mechanisms that depend on cumulative exposure, repeat dosing, or slower biological responses simply won't register in a short window
This substantial participant database provides meaningful safety evidence across varied dosing regimens, administration routes (oral and injectable), and treatment durations, making it one of the more extensively studied peptide fragments in human clinical trials
Obesity is a recognized epidemic